HedgeMountain

GMO Emerging Country Debt UCITS Fund, a sub-fund of GMO Investments ICAV

Boston, MA · CIK 1870343
506(c)

GMO Emerging Country Debt UCITS Fund, a sub-fund of GMO Investments ICAV is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Dec 11, 2025, the fund has sold $87,501,236 of interests to 4 investors since its first sale in Apr 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include David Bohan; Arron Day; Eimear Cowhey.

Total raised
$87,501,236Cumulative sales reported on Form D
Investors
4
First sale
Apr 1, 2020
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(c)May advertise; investors must be verified as accredited
Key people and entities
David Bohan; Arron Day; Eimear Cowhey
Latest Form D
Dec 11, 2025

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures

Size compared with every hedge fund

Raised more than 45% of the 472 hedge funds based in Massachusetts, and more than 55% of all 10,157 that report sales.

Other funds with the same team

More hedge funds in Boston